A new screening tool improves liver cancer detection

by Jordan Shaked,Yale UniversityTen-year risk of hepatocellular carcinoma (HCC). Credit:JAMA Network Open(2024). DOI: 10.1001/jamanetworkopen.2024.43608Hepatocellular carcinoma, a ty

Updated on: December 01,2024

A new screening tool improves liver cancer detection

by Jordan Shaked,Yale UniversityTen-year risk of hepatocellular carcinoma (HCC). Credit:JAMA Network Open(2024). DOI: 10.1001/jamanetworkopen.2024.43608Hepatocellular carcinoma, a ty

Updated on:December 01,2024

Team successfully generates mouse models for two subtypes of multiple myeloma

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineLeft: Normal bone marrow in the control animals with stained myeloid cells. Right: Bone marrow in the transgenic animals with pl

Updated on: January 07,2024

Team successfully generates mouse models for two subtypes of multiple myeloma

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineLeft: Normal bone marrow in the control animals with stained myeloid cells. Right: Bone marrow in the transgenic animals with pl

Updated on:January 07,2024

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on: April 01,2024

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on:April 01,2024

Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

by Katie Marquedant,Massachusetts General HospitalDistribution of recurrent melanomas in the study population. Among the 310 recurrent melanomas, 255 (82%) recurred within five years and 285 (92

Updated on: January 02,2024

Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

by Katie Marquedant,Massachusetts General HospitalDistribution of recurrent melanomas in the study population. Among the 310 recurrent melanomas, 255 (82%) recurred within five years and 285 (92

Updated on:January 02,2024

Genetic testing is important for women with breast cancer, expert says

by Rebecca Biason,University of TorontoCredit: Pixabay/CC0 Public DomainFor close to two decades Professor Kelly Metcalfe, a senior scientist at Women's College Research Institute and associ

Updated on: January 21,2024

Genetic testing is important for women with breast cancer, expert says

by Rebecca Biason,University of TorontoCredit: Pixabay/CC0 Public DomainFor close to two decades Professor Kelly Metcalfe, a senior scientist at Women's College Research Institute and associ

Updated on:January 21,2024

Study shines light on gut microbiome in colon cancer

by American Society for MicrobiologyMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaResearchers have identified a correlation between gut microbial com

Updated on: July 02,2024

Study shines light on gut microbiome in colon cancer

by American Society for MicrobiologyMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaResearchers have identified a correlation between gut microbial com

Updated on:July 02,2024

Arf1 inhibitors promote the infiltration of cytotoxic T lymphocytes into tumors by affecting lipid metabolism

by Higher Education PressScanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIHIn recent years, cancer immunotherapies, represented by immune checkpoint blockade (ICB), have b

Updated on: March 30,2024

Arf1 inhibitors promote the infiltration of cytotoxic T lymphocytes into tumors by affecting lipid metabolism

by Higher Education PressScanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIHIn recent years, cancer immunotherapies, represented by immune checkpoint blockade (ICB), have b

Updated on:March 30,2024

To rev-up CAR T-cell therapy, inhibit the SUSD2 membrane protein, study suggests

byOhio State University Medical CenterCredit: Pixabay/CC0 Public DomainInhibiting a particular protein in cancer-killing immune cells might improve the long-term effectiveness of CAR T-cell and

Updated on: January 22,2024

To rev-up CAR T-cell therapy, inhibit the SUSD2 membrane protein, study suggests

byOhio State University Medical CenterCredit: Pixabay/CC0 Public DomainInhibiting a particular protein in cancer-killing immune cells might improve the long-term effectiveness of CAR T-cell and

Updated on:January 22,2024

The 'Goldilocks' principle for curing brain cancer

by University of MinnesotaCancer cell during cell division. Credit: National Institutes of HealthIn the story of Goldilocks, a little girl tastes three different bowls of porridge to find which i

Updated on: April 10,2024

The 'Goldilocks' principle for curing brain cancer

by University of MinnesotaCancer cell during cell division. Credit: National Institutes of HealthIn the story of Goldilocks, a little girl tastes three different bowls of porridge to find which i

Updated on:April 10,2024

Drug combo heralds major shift in chronic lymphocytic leukemia treatment

by Stanford University Medical CenterCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteA combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and ali

Updated on: May 23,2024

Drug combo heralds major shift in chronic lymphocytic leukemia treatment

by Stanford University Medical CenterCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteA combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and ali

Updated on:May 23,2024

Study: Biomarker in urine may offer noninvasive detection of prostate cancer

by Henry Ford Health SystemNallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, examines prostate cancer cells. Credit: Henry Ford Hea

Updated on: March 01,2024

Study: Biomarker in urine may offer noninvasive detection of prostate cancer

by Henry Ford Health SystemNallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, examines prostate cancer cells. Credit: Henry Ford Hea

Updated on:March 01,2024

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on: January 30,2024

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on:January 30,2024